Jim Cramer Says This “Perfect Storm” Is The Biggest Threat To The Market

And it has nothing to to with China or the Fed…

CNBC’s Jim Cramer issued a new warning this week, one that’ll likely come as a surprise.

Right now, the market is worried about the trade war with China, the Fed raising interest rates and unwinding its balance sheet, the signs of a global economic slowdown. But Cramer says investors are ignoring the threat coming from the flood of IPOs that’s about to hit the market.

“I think the biggest threat to this bull market is denim,” Cramer said somewhat jokingly on Wednesday on CNBC’s “Mad Money” referring to the news that Levi Strauss had filed the paperwork to go public. “I, right now, at this very moment, am more worried about jeans than I am about China.”

While Cramer did say that the denim maker’s initial public offering looks like “an exciting deal,” he also noted that the IPO will likely cause investors to dump shares of stocks like Phillips-Van Heusen (NYSE: PVH) and Ralph Lauren (NYSE: RL) to get in on the IPO. And therein lies the danger.

“Now, maybe you think I’m being small-minded here – it’s just jeans, right? Wrong. See, it’s not just jeans,” he said. “We’re about to get a tsunami of new initial public offerings that will flood this stock market with new supply, and there simply isn’t enough money coming into the stock market to be able to handle all of this merchandise.”

That tsunami of new IPOs includes such big names as Uber, Lyft, Airbnb, Slack, Palantir, Pinterest, Postmates, and Reddit.

And these aren’t small deals. Uber has a possible valuation of $120 billion, Palantir was recently valued at $41 billion, Airbnb at $31 billion, Lyft at $15 billion, and social media company Pinterest at $12 billion. And with each of these, Cramer foresees a situation where investors sell other names in order to take advantage of these big newcomers to the market.

For example, when Slack goes public, money managers will likely sell shares of Atlassian (NASDAQ: TEAM)—a competing work collaboration platform—in order to buy shares of the new kid on the block as “they most likely won’t have much new money coming in to fund those purchases, so they need to sell something if they want to do any buying,” Cramer said.

And with each big IPO, the same scenario will play out. When Postmates goes public, investors  will ditch their shares of GrubHub (NYSE: GRUB). When cybersecurity company Palantir hits the market, investors will sell names like Palo Alto Networks (NYSE: PANW) or CyberArk (NASDAQ: CYBR). 

Cramer said that in order to buy Uber, big tech stocks including Facebook (NASDAQ: FB), Google parent Alphabet (NASDAQ: GOOGL, GOOG), and Apple (NASDAQ: AAPL) may act as a “source of funds” for money managers to raise capital for the ride-sharing giant.

“These will be natural sources of funds,” Cramer said. “Historically speaking, nothing slaughters a bull market as effectively as a burst of new IPOs and secondary offerings. Whenever this has happened in recent years, we’ve seen whole sectors crushed by a cascade of selling. It’s just the nature of the beast.”

And while these companies are of relatively high quality, Cramer’s worry is that the market won’t be able to sustain the coming IPO wave.

“My worry has to do with supply and demand,” he said. “When you get a surge of new supply without any increase in demand—meaning without much new money coming into the market—that’s going to be bad for prices of all stocks.”

“The bottom line? We are about to get hit with a perfect storm of IPOs, and regardless of how good this new merchandise might be, I’m concerned that the market won’t be able to handle it all without taking, maybe, all stocks lower,” Cramer warned. 

“More than anything else—China, the Fed, the possibility of another government shutdown—it’s this deluge of deals you should be worrying about because nobody else is.”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More